Sign In

Mark Martin

Managing Director at Houlihan Lokey

Mark Martin is a highly experienced professional serving as the Head of Pharma Commercialization investment banking at Houlihan. With a strong background in finance and entrepreneurship, Mark leads a diverse array of impactful pharma services and life sciences transactions. He has been actively involved in numerous notable transactions, including advising on sales, acquisitions, and partnerships within the pharmaceutical industry. Mark holds an MBA in Finance and Entrepreneurship from the University of Chicago Booth School of Business, complemented by a Bachelor's degree in Psychology from Pepperdine University.

Highlights

Jun 18 · linkedin

Excited to have partnered with Dan Renick and Micah Meisel (and their respective teams at Petauri and Oak Hill Capital) on their acquisition of Mtech Access and Delta Hat, further expanding Petauri's proficiency in market access and evidence-based value demonstration!

Jun 1 · linkedin

Excited to feature Doug Fulling, president of Precision AQ (formerly Precision Value & Health), in our latest TLIS! Doug discusses Precision AQ's rebrand, highlights the critical role of value and access in pharma commercialization today, and touches on other transformative industry factors.

#PrecisionAQ #PharmaIndustry #PharmaCommercialization #PrecisionforMedicine #PrecisionValueandHealth #MarketAccess #HoulihanLokey #PharmaServices

Mark Martin
Add to my network

Location

Malibu, California, United States